RANI icon

Rani Therapeutics

15 hedge funds and large institutions have $19.6M invested in Rani Therapeutics in 2021 Q3 according to their latest regulatory filings, with 15 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.

Holders
15
Holders Change
+15
Holders Change %
% of All Funds
0.26%
Holding in Top 10
1
Holding in Top 10 Change
+1
Holding in Top 10 Change %
%
% of All Funds
0.02%
New
15
Increased
Reduced
Closed
Calls
Puts
Net Calls
Net Calls Change
Name Market Value Shares Shares
Change
Shares
Change %
NFGH
1
Nan Fung Group Holdings
Hong Kong
$8.8M 493,584 +493,584 New
Vanguard Group
2
Vanguard Group
Pennsylvania
$5.05M 283,213 +283,213 New
CCM
3
CAAS Capital Management
New York
$1.34M 75,000 +75,000 New
Goldman Sachs
4
Goldman Sachs
New York
$1.08M 60,649 +60,649 New
Squarepoint
5
Squarepoint
New York
$891K 50,000 +50,000 New
Stifel Financial
6
Stifel Financial
Missouri
$676K 37,950 +37,950 New
Millennium Management
7
Millennium Management
New York
$517K 28,996 +28,996 New
Geode Capital Management
8
Geode Capital Management
Massachusetts
$385K 21,639 +21,639 New
State Street
9
State Street
Massachusetts
$351K 19,700 +19,700 New
Northern Trust
10
Northern Trust
Illinois
$204K 11,430 +11,430 New
CH
11
Canton Hathaway
Rhode Island
$178K 10,000 +10,000 New
UBS Group
12
UBS Group
Switzerland
$55K 3,070 +3,070 New
Bank of America
13
Bank of America
North Carolina
$26K 1,467 +1,467 New
Northwestern Mutual Wealth Management
14
Northwestern Mutual Wealth Management
Wisconsin
$18K 1,000 +1,000 New
Wells Fargo
15
Wells Fargo
California
$1K 40 +40 New
CFGS
16
Concourse Financial Group Securities
Alabama